IMVT compared with ROIV: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMVT: latest quarter not drawable. ROIV: latest quarter is a loss; flow not drawable.Method ›

IMVTImmunovant, Inc.

28.410.00%· post 29.00· delayed

Mkt cap$5.9BRevenue—Revenue—

ROIVRoivant Sciences Ltd.

35.89▲+0.01%· post 36.07· delayed

After hoursNov 3 '26delayed

Mkt cap$26.0BRevenue$1MQ1 FY26Revenue$8MFY25

Compare

After hoursNov 3 '26delayed

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

28.410.00%post 29.00delayed

Price

35.89▲+0.01%post 36.07delayed

$5.9B

Mkt cap

$26.0B

—

Revenue

$1MQ1 FY26

—

Revenue

$8MFY25

IMVT28.410.00%vsROIV35.89▲+0.01%After hoursNov 3 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—HanAllunlistedsupplier

Shared 0

No shared counterparties.

Only ROIV 6

IMVTImmunovantcustomer

—HanAll Biopharmaunlistedsupplier

—Sumitomo Pharmaunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Bayer

unlistedsupplier

2 more · ROIV chain ›

Price

rebased to 0%

IMVT, solidROIV, dashed